Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's DiseaseBrussels, Belgium, and Somerville, MA, March 15th, 2023 (18:00 CET): UCB, a global biopharmaceutical company, and Aitia, a leader in the application of Causal AI and “Digital Twins” to discover and develop new drugs, tod.
/PRNewswire/ UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI and "Digital Twins" to discover and develop new.